The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

NCT04996810 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Protox Inc.